Skip to main content
Clinical Trials/NCT05589649
NCT05589649
Completed
Not Applicable

Ultrasound-guided Erector Spinae Plane Block Versus Ultrasound-guided Thoracic Paravertebral Block in Pediatric Patients Undergoing Percutaneous Nephrolithotomy

Assiut University1 site in 1 country56 target enrollmentOctober 26, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Renal Stone
Sponsor
Assiut University
Enrollment
56
Locations
1
Primary Endpoint
Total consumption of nalbuphine
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

To compare the efficacy of ultrasound-guided erector spinae plane block versus ultrasound-guided paravertebral block in pediatric patients undergoing percutaneous nephrolithotomy

Detailed Description

Percutaneous Nephrolithotomy (PCNL) is a commonly performed surgical procedure for complex upper renal tract calculi. Although the skin incision for PCNL appears small, the intensity of intraoperative and postoperative pain is significant owing to soft tissue injury. Erector spinae plane (ESP) block is an interfascial block that was first described by Forero et al. in 2016. It can be performed by injecting the local anesthetic in the deep interfascial plane of the erector spinae muscle to provide both visceral and somatic analgesia with a sensory level from T2-4 to L1-2. . Paravertebral block is the technique of injecting local anesthetics in a space immediately lateral to where the spinal nerves emerge from the intervertebral foramina. This technique is used increasingly for intra-operative and post-operative.

Registry
clinicaltrials.gov
Start Date
October 26, 2022
End Date
December 27, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hany Mostafa Esmaeil Osman

Principal Investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing percutaneous nephrolithotomy

Exclusion Criteria

  • Coagulation disorders
  • Infection at the site of injection
  • Allergy to the local anesthetics used
  • Spinal cord abnormalities or neurological deficits

Outcomes

Primary Outcomes

Total consumption of nalbuphine

Time Frame: The first 24 hours postoperatively

Time to first rescue analgesia

Time Frame: The first 24 hours postoperatively

Secondary Outcomes

  • The concentration of sevoflurane in percent(Through the surgery, an average of 2 hours)
  • Systolic, diastolic, and mean blood pressure during surgery in mmHg(Through the surgery, an average of 2 hours)

Study Sites (1)

Loading locations...

Similar Trials